Stay updated on Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Sign up to get notified when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.

Latest updates to the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page
- Check7 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2. This reflects a minor revision applied to the page, usually for small fixes or updates.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and updated the 'Intervention/Treatment' heading (replacing the older 'Intervention / Treatment'). The changes also include the addition 'No longer looking for participants' and revision tag updated to v3.6.0.SummaryDifference0.3%

- Check28 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, signaling a small system or content update. This change does not modify study details or other user-visible content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page footer now shows an updated site revision number (from v3.5.2 to v3.5.3), indicating a new release of the ClinicalTrials.gov interface without altering the study information presented.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin in HL and CD30+ PTCL Clinical Trial page.